Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Barry Iacopetta
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Physiology
Phenomena
Procedures
Genes & Molecular Sequences
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
33
Grieu, Fabienne
24
Soong, Richie
20
Elsaleh, Hany
17
Joseph, David
9
House, Anthony
8
Powell, Brenda
8
Zeps, Nikolajs
7
Duval, Alex
7
Ruszkiewicz, Andrew
7
Platell, Cameron
7
Morris, Melinda
7
Hamelin, Richard
6
Salto-Tellez, Manuel
6
McCaul, Kieran
4
Shannon, BA
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Barry Iacopetta (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Whitehall Vicki; Tran Kayla; Umapathy Aarti; Grieu Fabienne; Hewitt Chelsee; Evans Tiffany-Jane; Ismail Tuty; Li Wei Qi; Collins Peter; Ravetto Paul; Leggett Barbara; Salto-Tellez Manuel; Soong Richie; Fox Stephen; Scott Rodney J; Dobrovic Alexander; Iacopetta Barry
A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting.
The Journal of molecular diagnostics : JMD 2009;11(6):543-52.
-
2009: Loh Marie; Koh King Xin; Yeo Boon Huat; Song Chun Meng; Chia Kee Seng; Zhu Feng; Yeoh Khay Guan; Hill Jeffrey; Iacopetta Barry; Soong Richie
Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race.
European journal of cancer (Oxford, England : 1990) 2009;45(14):2562-8.
-
2009: Smallwood L; Warrington N; Allcock R; van Bockxmeer F; Palmer L J; Iacopetta B; Golledge J; Norman P E
Matrix metalloproteinase-2 gene variants and abdominal aortic aneurysm.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2009;38(2):169-71.
-
2009: Iacopetta Barry; Heyworth Jane; Girschik Jennifer; Grieu Fabienne; Clayforth Cassandra; Fritschi Lin
The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer.
International journal of cancer. Journal international du cancer 2009;125(1):84-90.
-
2009: Krajewska Maryla; Smith Layton H; Rong Juan; Huang Xianshu; Hyer Marc L; Zeps Nikolajs; Iacopetta Barry; Linke Steven P; Olson Allen H; Reed John C; Krajewski Stan
Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2009;57(7):649-63.
-
2009: Soong R; Shah N; Peh B K; Chong P Y; Ng S S; Zeps N; Joseph D; Salto-Tellez M; Iacopetta B; Ito Y
The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome.
British journal of cancer 2009;100(5):676-9.
-
2009: Salama Paul; Phillips Michael; Grieu Fabienne; Morris Melinda; Zeps Nik; Joseph David; Platell Cameron; Iacopetta Barry
Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):186-92.
-
2009: Zhu Feng; Loh Marie; Hill Jeffrey; Lee Sumarlin; Koh King Xin; Lai Kin Wai; Salto-Tellez Manuel; Iacopetta Barry; Yeoh Khay Guan; Soong Richie;
Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study.
BMC gastroenterology 2009;9():76.
-
2008: Soong Richie; Anuar Diyanah; Liu Yanqun; Eu Kong W; Han Hwan C; Salto-Tellez Manuel; Iacopetta Barry
Denaturing high performance liquid chromatography for the detection of microsatellite instability using bethesda and pentaplex marker panels.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2008;17(3):127-33.
-
2008: Kawakami K; Ooyama A; Ruszkiewicz A; Jin M; Watanabe G; Moore J; Oka T; Iacopetta B; Minamoto T
Low expression of gamma-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype.
British journal of cancer 2008;98(9):1555-61.
-
2008: Soong R; Shah N; Salto-Tellez M; Tai B C; Soo R A; Han H C; Ng S S; Tan W L; Zeps N; Joseph D; Diasio R B; Iacopetta B
Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):915-9.
-
2008: Tan Yi Hui; Liu Yanqun; Eu Kong Weng; Ang Pei Woon; Li Wei Qi; Salto-Tellez Manuel; Iacopetta Barry; Soong Richie
Detection of BRAF V600E mutation by pyrosequencing.
Pathology 2008;40(3):295-8.
-
2008: Spry Nigel; Harvey Jennifer; Macleod Craig; Borg Martin; Ngan Samuel Y; Millar Jeremy L; Graham Peter; Zissiadis Yvonne; Kneebone Andrew; Carroll Susan; Davies Terri; Reece William H H; Iacopetta Barry; Goldstein David
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.
International journal of radiation oncology, biology, physics 2008;70(5):1438-46.
-
2008: Morris Melinda; Platell Cameron; Iacopetta Barry
Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1413-7.
-
2008: Samowitz Wade S; Broaddus Russell; Iacopetta Barry; Goldblatt Jack
PCR versus immunohistochemistry for microsatellite instability.
The Journal of molecular diagnostics : JMD 2008;10(2):181-2; author reply 181.
-
2008: Ang Pei Woon; Toh Hwee Boon; Iacopetta Barry; Soong Richie
An improved quality control for bisulfite-PCR-based DNA methylation analysis: cycle threshold value.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(8):1117-21.
-
2007: Watson Natasha; Grieu Fabienne; Morris Melinda; Harvey Jennet; Stewart Colin; Schofield Lyn; Goldblatt Jack; Iacopetta Barry
Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer.
The Journal of molecular diagnostics : JMD 2007;9(4):472-8.
-
2007: Iacopetta Barry; Grieu Fabienne; Phillips Michael; Ruszkiewicz Andrew; Moore James; Minamoto Toshinari; Kawakami Kazuyuki
Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa.
Cancer science 2007;98(9):1454-60.
-
2007: Morris Melinda; Platell Cameron; McCaul Kieran; Millward Michael; van Hazel Guy; Bayliss Evan; Trotter James; Ransom David; Iacopetta Barry
Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting.
International journal of colorectal disease 2007;22(8):887-95.
-
2007: Morris Melinda; Platell Cameron; Iacopetta Barry
A population-based study of age-related variation in clinicopathological features, molecular. Markers and outcome from colorectal cancer.
Anticancer research 2007;27(4C):2833-8.
-
2007: Iacopetta Barry; Platell Cameron
Population-based screening for hereditary non-polyposis colorectal cancer (Lynch Syndrome): the Western Australian approach.
ANZ journal of surgery 2007;77(4):197-8.
-
2007: Morris Melinda; Iacopetta Barry; Platell Cameron
Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals.
The Medical journal of Australia 2007;186(6):296-300.
-
2007: Morris M; Platell C; Fritschi L; Iacopetta B
Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients.
British journal of cancer 2007;96(5):701-7.
-
2007: Zeps Nikolajs; Iacopetta Barry J; Schofield Lyn; George Jillian M; Goldblatt Jack
Waiver of individual patient consent in research: when do potential benefits to the community outweigh private rights?
The Medical journal of Australia 2007;186(2):88-90.
-
2007: Chin Tan Min; Anuar Diyanah; Soo Ross; Salto-Tellez Manuel; Li Wei Qi; Ahmad Baidah; Lee Soo Chin; Goh Boon Cher; Kawakami Kazuyuki; Segal Amanda; Iacopetta Barry; Soong Richie
Detection of epidermal growth factor receptor variations by partially denaturing HPLC.
Clinical chemistry 2007;53(1):62-70.
-
2006: Hugo Honor; Cures Alina; Suraweera Nirosha; Drabsch Yvette; Purcell Damian; Mantamadiotis Theo; Phillips Wayne; Dobrovic Alex; Zupi Gabriella; Gonda Thomas J; Iacopetta Barry; Ramsay Robert G
Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers.
Genes, chromosomes & cancer 2006;45(12):1143-54.
-
2006: Iacopetta Barry; Grieu Fabienne; Li Wei; Ruszkiewicz Andrew; Caruso Maria; Moore James; Watanabe Goh; Kawakami Kazuyuki
APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer.
International journal of cancer. Journal international du cancer 2006;119(10):2272-8.
-
2006: Iacopetta B; Li W Q; Grieu F; Ruszkiewicz A; Kawakami K
BRAF mutation and gene methylation frequencies of colorectal tumours with microsatellite instability increase markedly with patient age.
Gut 2006;55(8):1213-4.
-
2006: Iacopetta Barry
Methyl-group metabolism and the response of colorectal cancer to 5-fluorouracil.
Critical reviews in oncogenesis 2006;12(1-2):115-26.
-
2006: Morris M; Platell C; de Boer B; McCaul K; Iacopetta B
Population-based study of prognostic factors in stage II colonic cancer.
The British journal of surgery 2006;93(7):866-71.
-
2006: Li ShaoYing; Rong Minna; Iacopetta Barry
DNA hypermethylation in breast cancer and its association with clinicopathological features.
Cancer letters 2006;237(2):272-80.
-
2006: Li Shao Ying; Rong Minna; Grieu Fabienne; Iacopetta Barry
PIK3CA mutations in breast cancer are associated with poor outcome.
Breast cancer research and treatment 2006;96(1):91-5.
-
2006: Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
British journal of cancer 2006;94(4):593-8.
-
2006: Feng Han Qian; Zhao Wenying; Bentel Jacky; Shearwood Anne-Marie; Zeps Nik; Joseph David; Iacopetta Barry; Dharmarajan Arun
Expression of sFRP-4 and beta-catenin in human colorectal carcinoma.
Cancer letters 2006;231(1):129-37.
-
2006: Li Shao Ying; Rong Minna; Iacopetta Barry
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.
Oncology reports 2006;15(1):221-5.
-
2006: Li Wei Qi; Kawakami Kazuyuki; Ruszkiewicz Andrew; Bennett Graeme; Moore James; Iacopetta Barry
BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.
Molecular cancer 2006;5():2.
-
2005: Russo Antonio; Bazan Viviana; Iacopetta Barry; Kerr David; Soussi Thierry; Gebbia Nicola;
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7518-28.
-
2005: Koay M H Eleanor; Goh Yu-Wei; Iacopetta Barry; Grieu Fabienne; Segal Amanda; Sterrett Gregory F; Platten Michael; Spagnolo Dominic V
Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.
Pathology 2005;37(1):22-31.
-
2005: Elsaleh Hany; Iacopetta Barry
Re: Pooled analysis of fluorouracil-based adjuvant therapy of stage II and III colon cancer: who benefits and by how much?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):653-4; author reply 654-5.
-
2004: Grieu Fabienne; Li Wei Qi; Iacopetta Barry
Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Breast cancer research and treatment 2004;88(3):197-204.
-
2004: Chai Siaw Ming; Zeps Nik; Shearwood Anne-Marie; Grieu Fabienne; Charles Adrian; Harvey Jennet; Goldblatt Jack; Joseph David; Iacopetta Barry
Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(11):1017-25.
-
2004: Grieu Fabienne; Powell Brenda; Beilby John; Iacopetta Barry
Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype.
Anticancer research 2004;24(5B):3215-9.
-
2004: Grieu Fabienne; Joseph David; Norman Paul; Iacopetta Barry
Development of a rapid genotyping method for single nucleotide polymorphisms and its application in cancer studies.
Oncology reports 2004;11(2):501-4.
-
2004: Iacopetta B; Grieu F; Joseph D
The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype.
British journal of cancer 2004;90(2):419-22.
-
2003: Kawakami Kazuyuki; Ruszkiewicz Andrew; Bennett Graeme; Moore James; Watanabe Go; Iacopetta Barry
The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5860-5.
-
2003: Iacopetta Barry; Elsaleh Hany; Zeps Nik
Microsatellite instability in colon cancer.
The New England journal of medicine 2003;349(18):1774-6; author reply 1774-6.
-
2003: Grieu Fabienne; Malaney Suzann; Ward Robyn; Joseph David; Iacopetta Barry
Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Anticancer research 2003;23(5b):4257-9.
-
2003: Van Rijnsoever Marius; Elsaleh Hany; Joseph David; McCaul Kieran; Iacopetta Barry
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):2898-903.
-
2003: Powell B L; Piersma D; Kevenaar M E; van Staveren I L; Themmen A P N; Iacopetta B J; Berns E M J J
Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset.
The Journal of clinical endocrinology and metabolism 2003;88(4):1653-7.
-
2003: Iacopetta Barry
Aberrant DNA methylation: have we entered the era of more than one type of colorectal cancer?
The American journal of pathology 2003;162(4):1043-5.
-
2003: Iacopetta Barry
TP53 mutation in colorectal cancer.
Human mutation 2003;21(3):271-6.
-
2003: Wang Cathy; van Rijnsoever Marius; Grieu Fabienne; Bydder Sean; Elsaleh Hsny; Joseph David; Harvey Jennet; Iacopetta Barry
Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer.
Oncology 2003;64(3):259-65.
-
2002: Suraweera Nirosha; Duval Alex; Reperant Maryline; Vaury Christelle; Furlan Daniela; Leroy Karen; Seruca Raquel; Iacopetta Barry; Hamelin Richard
Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR.
Gastroenterology 2002;123(6):1804-11.
-
2002: van Rijnsoever M; Grieu F; Elsaleh H; Joseph D; Iacopetta B
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands.
Gut 2002;51(6):797-802.
-
2002: Iacopetta Barry
Are there two sides to colorectal cancer?
International journal of cancer. Journal international du cancer 2002;101(5):403-8.
-
2002: Elsaleh Hany; Cserni Gábor; Iacopetta Barry
Extent of nodal involvement in Stage III colorectal carcinoma: relationship to clinicopathologic variables and genetic alterations.
Diseases of the colon and rectum 2002;45(9):1218-22.
-
2002: Shannon B; Gnanasampanthan S; Beilby J; Iacopetta B
A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability.
Gut 2002;50(4):520-4.
-
2002: Duval Alex; Reperant Maryline; Compoint Aurore; Seruca Raquel; Ranzani Guglielmina N; Iacopetta Barry; Hamelin Richard
Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency.
Cancer research 2002;62(6):1609-12.
-
2002: Powell Brenda L; van Staveren Iris L; Roosken Paul; Grieu Fabienne; Berns Els M J J; Iacopetta Barry
Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer.
Carcinogenesis 2002;23(2):311-5.
-
2002: van Rijnsoever Marius; Elsaleh Hany; Iacopetta Barry
Microsatellite instability in colorectal cancer: prognostic, predictive or both?
The American journal of pathology 2002;160(1):384-5; author reply 385-6.
-
2001: Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
The Journal of pathology 2001;195(5):543-8.
-
2001: Suraweera N; Iacopetta B; Duval A; Compoint A; Tubacher E; Hamelin R
Conservation of mononucleotide repeats within 3' and 5' untranslated regions and their instability in MSI-H colorectal cancer.
Oncogene 2001;20(51):7472-7.
-
2001: Duval A; Iacopetta B; Thorstensen L; Meling G I; Lothe R A; Thuille B; Suraweera N; Thomas G; Hamelin R
Gender difference for mismatch repair deficiency in human colorectal cancer.
Gastroenterology 2001;121(4):1026-7.
-
2001: Powell B L; Bydder S; Grieu F; Gnanasampanthan G; Elsaleh H; Seshadri R; Berns E M; Iacopetta B
Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients.
Breast cancer research and treatment 2001;69(1):65-8.
-
2001: Iacopetta B; Grieu F; Joseph D; Elsaleh H
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
British journal of cancer 2001;85(6):827-30.
-
2001: Elsaleh H; Iacopetta B
Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
Clinical colorectal cancer 2001;1(2):104-9.
-
2001: Shannon B A; Iacopetta B J
Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: associations with clinicopathological features.
Cancer letters 2001;167(1):91-7.
-
2001: Elsaleh H; Powell B; McCaul K; Grieu F; Grant R; Joseph D; Iacopetta B
P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1343-9.
-
2001: Elsaleh H; Shannon B; Iacopetta B
Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy.
Gastroenterology 2001;120(5):1309-10.
-
2001: Duval A; Rolland S; Compoint A; Tubacher E; Iacopetta B; Thomas G; Hamelin R
Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers.
Human molecular genetics 2001;10(5):513-8.
-
2000: Cohen R J; McNeal J E; Susman M; Sellner L N; Iacopetta B J; Weinstein S L; Dawkins H J
Sarcomatoid renal cell carcinoma of papillary origin. A case report and cytogenic evaluation.
Archives of pathology & laboratory medicine 2000;124(12):1830-2.
-
2000: Soong R; Powell B; Elsaleh H; Gnanasampanthan G; Smith D R; Goh H S; Joseph D; Iacopetta B
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation.
European journal of cancer (Oxford, England : 1990) 2000;36(16):2053-60.
-
2000: Elsaleh H; Robbins P; Joseph D; Powell B; Grieu F; Menso L; Iacopetta B
Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;56(2):239-44.
-
2000: Elsaleh H; Joseph D; Grieu F; Zeps N; Spry N; Iacopetta B
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.
Lancet 2000;355(9217):1745-50.
-
2000: Iacopetta B; Grieu F
Routine detection of the replication error phenotype in clinical tumor specimens using fluorescence-SSCP.
BioTechniques 2000;28(3):566-8, 570.
-
2000: Iacopetta B; Elsaleh H; Grieu F; Joseph D; Sterrett G; Robbins P
Routine analysis of p53 mutation in clinical breast tumor specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2000;9(1):20-5.
-
2000: Powell B; Soong R; Iacopetta B; Seshadri R; Smith D R
Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):443-51.
-
2000: Elsaleh H; Powell B; Soontrapornchai P; Joseph D; Goria F; Spry N; Iacopetta B
p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.
Oncology 2000;58(1):52-9.
-
1999: Elsaleh H; Soontrapornchai P; Grieu F; Joseph D; Iacopetta B
P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas.
International journal of oncology 1999;15(6):1239-43.
-
1999: Soontrapornchai P; Elsaleh H; Joseph D; Hamdorf J M; House A K; Iacopetta B
TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value.
European journal of cancer (Oxford, England : 1990) 1999;35(12):1683-7.
-
1999: Duval A; Iacopetta B; Ranzani G N; Lothe R A; Thomas G; Hamelin R
Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability.
Oncogene 1999;18(48):6806-9.
-
1999: Duval A; Gayet J; Zhou X P; Iacopetta B; Thomas G; Hamelin R
Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability.
Cancer research 1999;59(17):4213-5.
-
1999: Shannon B; Kay P; House A; Iacopetta B
Hypermethylation of the MYF-3 gene in colorectal cancers: associations with pathological features and with microsatellite instability.
International journal of cancer. Journal international du cancer 1999;84(2):109-13.
-
1999: Iacopetta B J; Soong R; House A K; Hamelin R
Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes.
The Journal of pathology 1999;187(4):428-32.
-
1999: Powell B; Soong R; Grieu F; Knowles S; Hammond I; Iacopetta B
p53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma.
International journal of oncology 1999;14(1):175-9.
-
1999: Soong R; Knowles S; Hammond I G; Michael C; Iacopetta B J
p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.
Cancer detection and prevention 1999;23(1):8-12.
-
1998: Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R
Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(7):1597-602.
-
1998: Iacopetta B J; Welch J; Soong R; House A K; Zhou X P; Hamelin R
Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations.
The Journal of pathology 1998;184(4):390-5.
-
1998: Iacopetta B; Hamelin R
Rapid and nonisotopic SSCP-based analysis of the BAT-26 mononucleotide repeat for identification of the replication error phenotype in human cancers.
Human mutation 1998;12(5):355-60.
-
1997: Soong R; Iacopetta B J; Harvey J M; Sterrett G F; Dawkins H J; Hahnel R; Robbins P D
Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer.
International journal of cancer. Journal international du cancer 1997;74(6):642-7.
-
1997: Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
p53 alterations are associated with improved prognosis in distal colonic carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1405-11.
-
1997: Iacopetta B J; Harmon D; Spagnolo D V; House A K; Kay P H
Hypermethylation of the Myf-3 gene in human colorectal cancer.
Anticancer research 1997;17(1A):429-32.
-
1996: Soong R; Robbins P D; Dix B R; Grieu F; Lim B; Knowles S; Williams K E; Turbett G R; House A K; Iacopetta B J
Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas.
Human pathology 1996;27(10):1050-5.
-
1996: Wysocki S J; Zheng M H; Smith A; Lamawansa M D; Iacopetta B J; Robertson T A; Papadimitriou J M; House A K; Norman P E
Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages.
Journal of cellular biochemistry 1996;62(3):303-13.
-
1996: Soong R; Knowles S; Williams K E; Hammond I G; Wysocki S J; Iacopetta B J
Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma.
British journal of cancer 1996;74(4):562-7.
-
1996: Lim B H; Soong R; Grieu F; Robbins P D; House A K; Iacopetta B J
p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma.
International journal of cancer. Journal international du cancer 1996;69(3):200-4.
-
1996: Callus B A; Iacopetta B J; Kühn L C; Morgan E H
Effects of overexpression of the transferrin receptor on the rates of transferrin recycling and uptake of non-transferrin-bound iron.
European journal of biochemistry / FEBS 1996;238(2):463-9.
-
1995: Dix B R; Robbins P D; Spagnolo D V; Padovan G L; House A K; Iacopetta B J
Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1995;4(4):261-5.
-
1995: Sparrow L E; Soong R; Dawkins H J; Iacopetta B J; Heenan P J
p53 gene mutation and expression in naevi and melanomas.
Melanoma research 1995;5(2):93-100.
-
1994: Dix B R; Robbins P; Soong R; Jenner D; House A K; Iacopetta B J
The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival.
International journal of cancer. Journal international du cancer 1994;59(6):747-51.
-
1994: Dix B; Robbins P; Carrello S; House A; Iacopetta B
Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
British journal of cancer 1994;70(4):585-90.
-
1994: Iacopetta B; DiGrandi S; Dix B; Haig C; Soong R; House A
Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma.
European journal of cancer (Oxford, England : 1990) 1994;30A(5):664-70.
-
1994: Wysocki S J; Iacopetta B J; Ingram D M
Prognostic significance of pS2 mRNA in breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(12):1882-4.
-
1993: Dargemont C; Le Bivic A; Rothenberger S; Iacopetta B; Kühn L C
The internalization signal and the phosphorylation site of transferrin receptor are distinct from the main basolateral sorting information.
The EMBO journal 1993;12(4):1713-21.
-
1992: Iacopetta B J; Grieu F; Horisberger M; Sunahara G I
Epidermal growth factor in human and bovine milk.
Acta paediatrica (Oslo, Norway : 1992) 1992;81(4):287-91.
-
1988: Iacopetta B J; Rothenberger S; Kühn L C
A role for the cytoplasmic domain in transferrin receptor sorting and coated pit formation during endocytosis.
Cell 1988;54(4):485-9.
-
1987: Rothenberger S; Iacopetta B J; Kühn L C
Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site.
Cell 1987;49(3):423-31.
Sign-in to see more